Management of epilepsy in women.
Journal
The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
23
05
2018
revised:
19
11
2018
accepted:
10
12
2018
pubmed:
13
3
2019
medline:
5
6
2020
entrez:
13
3
2019
Statut:
ppublish
Résumé
Epilepsy is a common neurological condition in women worldwide. Hormonal changes occurring throughout a woman's life can influence and be influenced by seizure mechanisms and antiepileptic drugs, presenting unique management challenges. Effective contraception is particularly important for women with epilepsy of childbearing potential because of antiepileptic drug-related teratogenicity and hormonal interactions; although studies reveal many women do not receive contraceptive and preconceptual counselling. Management challenges in this population include the higher risk of pregnancy complications and peripartum psychiatric problems than in women without epilepsy. Research is needed to clarify the precise role of folic acid supplementation in prevention of congenital malformations in children born to women with epilepsy. To optimise treatment of low bone density in women with epilepsy, studies investigating bone densitometry frequency and calcium and vitamin D supplements are required. Understanding of the mechanisms linking seizures and the menopause will help to develop effective therapeutic strategies, and advances in managing epilepsy could improve quality of life for women with this condition.
Identifiants
pubmed: 30857949
pii: S1474-4422(18)30495-2
doi: 10.1016/S1474-4422(18)30495-2
pii:
doi:
Substances chimiques
Anticonvulsants
0
Hormones
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
481-491Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.